Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
.071 a share. 68 trades today. $36 k in trades . Sellers out numbered buyers 2 to 1. Not ready for prime time.
Currently the RSI is 24.19 {very oversold} . It also has 5 weeks in a row down trend on LESS than avg volume.
Reminder - Green Thumb Industries to Hold First Quarter 2022 Earnings Conference Call on May 4, 2022
MARCH 30, 2022
CHICAGO and VANCOUVER, British Columbia, March 30, 2022 (GLOBE NEWSWIRE) -- Green Thumb Industries Inc. (Green Thumb) (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer packaged goods company and owner of RYTHM, Dogwalkers and incredibles branded cannabis products, today announced it will hold a conference call on Wednesday, May 4, 2022, at 5:00 p.m. ET following the release of its first quarter 2022 financial results.
19.69 as I type
Trulieve Cannabis Corp. to Hold First Quarter 2022 Results Conference Call on May 12, 2022
Today 8:00 AM ET (PR NewsWire)Print
Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., will hold a conference call on Thursday, May 12, 2022 at 8:30 AM Eastern Time following the release of its first quarter 2022 financial results.
https://mma.prnewswire.com/media/1720011/Trulieve_Logo.jpg
Chairman, Founder, and Chief Executive Officer Kim Rivers, Chief Financial Officer Alex D'Amico, and President Steve White will participate on the call to review Trulieve's financial and operating results.
Interested parties can join the conference call by dialing in as directed below. Participants are asked to request the Trulieve Cannabis Corp. call. Please dial in 15 minutes prior to the call.
The sector is giving a look of wanting to turn, if so, perhaps it will take this one with it.
Ok, that's for that.
Is it just me or is the FL OMMU stats a little light this week?
Yes, in about 12-14 days
Wasn't that a month ago?
Ayr Wellness Opens 46th Florida Dispensary in Tampa
Today 7:30 AM ET (GlobeNewswire)Print
Ayr Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) ("Ayr" or the "Company"), a leading vertically integrated U.S. multi-state cannabis operator (MSO), today announced the opening of its 46 Florida dispensary, located in southern Tampa.
The new dispensary encompasses ~3,000 square feet of retail space in Hillsborough County, and is located just off the Dale Mabry Highway, an artery connecting several major shopping destinations, MacDill Air Force Base and Tampa International Airport. The store features Ayr's full line of concentrates, edibles, gummies, vapes, and a selection of high-quality flower, including whole flower and pre-rolls.
"We are proud to welcome the latest addition to our Florida footprint," said Jonathan Sandelman, Founder, Chairman and CEO of Ayr. "This opening, our 46 in the state, coincides with the recent launch of Kynd premium flower and Walking STIX pre-rolls, representing further expansion of our product portfolio and selection of high-quality product offerings available to our Florida patients."
In February 2021, Ayr purchased Florida-based Liberty Health Sciences ("LHS" or "Liberty"), which included 31 dispensaries across the state. Since then, the Company has opened 15 additional locations - bringing the current total to 46 stores. This location marks Ayr's fourth LHS location serving patients in the Hillsborough area.
In 2021, Ayr relocated its U.S. headquarters from New York City to Miami, underscoring the Company's commitment to the region. Florida has ~710,000 patients enrolled in its medical marijuana program as of April 22, 2022, per Florida OMMU. Florida's cannabis market ranks fourth in the nation by total legal cannabis sales, per BDSA, and generated over $1.8 billion in medical cannabis revenue in 2021. BDSA expects Florida's cannabis market to generate $3.4 billion per year by 2026.
Trulieve CEO Kim Rivers Receives Green Market Report Women's Leadership Award
Today 4:15 PM ET (PR NewsWire)Print
Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the United States, today announced that its Chief Executive Officer Kim Rivers has won Green Market Report's Women's Leadership Award in the C-Suite category.
https://mma.prnewswire.com/media/1807276/Trulieve_Cannabis_Corp_Kim_Rivers.jpg
In the last year, Rivers has been the driving force behind several major business developments in the cannabis industry, including Trulieve's leading retail footprint in U.S. cannabis, industry leading profitability, and transformational purchase of Harvest Health and Recreation. Rivers set a new industry standard with Trulieve's release of its inaugural Environmental, Social, and Governance (ESG) report, the first issued by an American multi-state cannabis operator.
The Women's Leadership Award honors women in the cannabis industry for their work in several different categories including Activism/Politics, Social Equity, Cultivation, and Media.
"It's an honor to be recognized amongst so many talented leaders who are redefining this industry," said Rivers. "As the only female-led public multi-state operator, Trulieve has a unique opportunity to increase female representation and ownership within the sector. It's also important to use this platform to foster significant economic and social advancement opportunities for local communities across the country. I look forward to a future when female leadership is ubiquitous in the C-Suite."
The Women's Leadership Award ceremony was held during Green Market Report Women's Summit in New York City on April 28th. The event was attended by many of the most successful women in the cannabis industry. Winners of Green Market Report's Women's Leadership Award were nominated and selected by a panel of industry insiders.
Just a fyi - WEED Options Listed For Trading
Today 9:01 AM ET (PR NewsWire)Print
Roundhill Investments, an ETF sponsor focused on developing innovative thematic funds, is pleased to announce that options for WEED -- the Roundhill Cannabis ETF -- are now listed for trading on Cboe's options exchanges.
The Roundhill Cannabis ETF ("WEED ETF") is designed to offer investors exposure to the cannabis sector. The fund invests in various cannabis related companies, including: (i) cannabis producers and distributors, (ii) cannabis-related technology companies, and (iii) additional cannabis related ancillary businesses.
WEED's top holdings (as of 4/27/2022) include Curaleaf Holdings (13.0% weight), Green Thumb Industries (9.9% weight), Trulieve Cannabis (8.0% weight), and Verano Holdings (7.3% weight).
For more information on WEED ETF and a full list of holdings please visit:https://www.roundhillinvestments.com/etf/weed/.
About Roundhill Investments:
Roundhill Investments is a U.S.-based investment adviser focused on developing innovative exchange-traded products. The firm's product lineup currently accounts for more than $1 billion in assets under management. To learn more about the company, please visit roundhillinvestments.com.
Investors should consider the investment objectives, risk, charges, and expenses carefully before investing. For a prospectus or summary prospectus with thiGTIIs and other information about the WEED ETF please call 1-855-561-5728 or visit the website https://www.roundhillinvestments.com/etf/weed/. Read the prospectus and summary prospectus carefully before investing.
Companies involved in the cannabis industry face intense competition, may have limited access to the services of banks, may have substantial burdens on company resources due to litigation, complaints or enforcement actions, and are heavily dependent on receiving necessary permits and authorizations to engage in medical cannabis research or to otherwise cultivate, possess or distribute cannabis. Since the cultivation, possession, and distribution of cannabis can be illegal under United States federal law under certain circumstances, federally regulated banking institutions may be unwilling to make financial services available to growers and sellers of cannabis.
Cannabis-related companies are subject to various laws and regulations that may differ at the state/local and federal level. Laws and regulations related to the possession, use (medical or recreational), sale, transport and cultivation of marijuana vary throughout the world, and the Fund will only invest in non-U.S. Cannabis Companies if such companies are operating legally in the relevant jurisdiction. These laws and regulations may (i) significantly affect a cannabis-related company's ability to secure financing, (ii) impact the market for marijuana industry sales and services, and (iii) set limitations on marijuana use, production, transportation, and storage.
In addition, cannabis-related companies are subject to the risks associated with the greater agricultural industry, including changes to or trends that affect commodity prices, labor costs, weather conditions, and laws and regulations related to environmental protection, health and safety. Cannabis-related companies may also be subject to risks associated with the biotechnology and pharmaceutical industries. These risks include increased government regulation, the use and enforcement of intellectual property rights and patents, technological change and obsolescence, product liability lawsuits, and the risk that research and development may not necessarily lead to commercially successful products.
As an ETF, the fund may trade at a premium or discount to NAV. Shares of any ETF are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Due to the costs of buying or selling Shares, including brokerage commissions imposed by brokers and bid/ask spreads, frequent trading of Shares may significantly reduce investment results and an investment in Shares may not be advisable for investors who anticipate regularly making small investments. The Fund is a recently organized investment company with no operating history. Please see the prospectus for details of these and other risks.
Roundhill Financial Inc. serves as the investment advisor. The Funds are distributed by Foreside Fund Services, LLC which is not affiliated with Roundhill Financial Inc., U.S. Bank, or any of the companies or individuals referenced herein.
First, I appreciate your thoughts. Thank you. I’m coming from a possible different direction. Exploring really. Most of the bigger hitters in this sector {mso} were down roughly 5 to 8 percent yesterday. There was no news to account for that. The MJ was at breakeven. However, MSOS which deals in swaps was down 5 percent and PSDN which runs a leverage game was down 8.
In TCNNF we have a stock that is already oversold by rsi, no bad news, being sold off on higher volume. If it was just this stock going down, we’ll ,sure ,ok . But all main players going down on higher volume, many of which are already oversold, on no news. That deserves a harder look.
In regards to sell in May and walk away, it’s still selling off from last May. LOL
I don't think it was just traders, and it wasn't just this company as the whole sector took a hit. Could be the ETF's and if so would look hard at PSDN, I guess the others as well. Whatever hit this sector I better figure it out by the morning.
Well, you are doing better than me. Even after the avg down my overall cost avg is 14k in shares at 16.10 . It is what it is. Started out some other positions but all in all it's a bad day.
Trulieve Acquires Greenhouse Wellness West Virginia
Today 7:43 AM ET (PR NewsWire)Print
Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) "Trulieve" or "the Company"), a leading and top-performing cannabis company in the United States, today announced the closing of the acquisition of Greenhouse Wellness West Virginia Dispensaries LLC ("Greenhouse"), holder of a West Virginia dispensary permit. Trulieve paid an immaterial amount of cash consideration for the transaction.
https://mma.prnewswire.com/media/1720011/Trulieve_Logo_2020_Logo.jpg
Greenhouse was awarded the dispensary permit in Martinsburg, West Virginia, in January 2021. This location, combined with Trulieve's nine other dispensary permits, are spread across many of the most populous areas in the state. Trulieve currently operates medical dispensaries in Morgantown and Weston. Several new locations are slated to open throughout the state in the coming months.
"This acquisition broadens our ever-expanding presence in West Virginia," said Kim Rivers, CEO of Trulieve. "We now have cultivation, processing and 10 dispensary permits in the state. Trulieve is committed to investing in communities where we operate and will serve West Virginia patients by offering expanded access to high quality products and providing exceptional customer experiences."
The transaction has been approved by the West Virginia Department of Health and Human Resources.
So do I. It helps that the sector is also over sold.
Yes it is
Losing the CFO, I see. Well, he did put in a hard 9mo there, got everything heading in a direction. Clearly his work was done. But I do wonder where he will be going, I mean he’s leaving this “the incredible future we have ahead at Charlotte's Web 2.0”. Can you imagine how great that opportunity was to leave the incredible future as stated. Gee, I want to know where he’s going, that would be the hot spot.
Into a pretty hard over sold right now per the charts.
Who's buying, I am. And I have plenty of money to do so. Far more cash then I would like. In regards to the dot com days, were not there yet, but it could turn into it. Just keeping tight lines on everything.
Well, been spending much of my investment time focused on the macro lately. However, lets look at the 3 statements you made from, say the 30000-foot level.
Circumvent the shareholders.
Yes it has been recognized. Yes it is a fact.
Concerning of the long-term plans.
Yes, we don’t know the why’s of what they are doing. IMO they are setting up to extend the game in the hope of growing later, and to be frank still being able to collect a paycheck.
Difficult to gain NEW serious investor interest.
That’s happening now. However, the story is still incomplete. If nothing changes, you would be right. If they increase the sales, come out with a new product/s and become profitable, the investors will follow.
At the end to the day the current state of this company has been unsuccessful. They need to become a successfully run business to survive and the clock is ticking. IMO
Well, first I hope your right with your thoughts. I’m not that optimistic. I feel they don’t care anywhere near as much about the shareholder meeting. They’re getting the R/S and the ability to dilute because they rigged it that way, going around any input the shareholders may have had, it failed them last year to allow the shareholders to have any say. They have a long, long way to go to be seen as competent, but they do have the reins to do whatever they want, so.
They simply didn’t have the money, the position or the leadership to “push hard”. If it was that easy to flip that switch, they would have done it long ago. 2022 is shaping up to be a very tough year for the sector, markets and economy in general. If they do have a hail mary in their pocket, now would be the time to throw it.
Whatever you say, First 4 hours, 15 trades, 1950 dollars total , selling volume out dueling buyers 2-1, not that it matters. It’s about as close as you can get to dead in the water.
Well, as I stated will be watching the trading action on this one after the ER. Today 90 min in 5 trades avg of 200 dollars per trade.
There has not been shorts, naked shorts, Momo players or much of anything else. Currently dead in the water.
JH - Director of Business Development -- fail
Well, in regards to “has not maximized sales” and “sense of urgency” and “lack of attention” all more or less true.
However, on the tons of potential, debatable. I’m weighting what exactly that true potential really is, in regards to what they realistically can do. And yes I'm aware of FDA and 007, I'm still weighting out what that will mean without just blue sky thinking.
Regarding Dowling, my thoughts go to, if there were a replacement, what exactly would that replacement have to work with. Would it really be any better? Are there moves that could be made that are positive from a shareholder point of view or did Dowling run it down to far. Yes, there are moves to be made, but again I’m looking at the shareholders pov, not collecting a company check pov.
You state can't keep profitable business down, sure you can. BYW didn't they lose .49 cents a share last qt? P/S at 3.59? Just saying, it's a good company but now is not the time to pump.
34 trades today at roughly 325 per trade. We'll call that lack of interest.
95 trades today at roughly $300 per trade. Not so good.
It’s just not that complex. Either cut costs in a major fashion, or create sales in a major fashion, or extend the game in the hopes that you can to so later, and that’s up for debate. In any event they choose to extend the game. They will get paid just fine, it’s the shareholders that will take the hit. IMO.
No reason to lobby, I’m fully capable to decide how to vote.
You are being very generous with that statement. The operating loss was 147 million last year vs a loss of 50 million the year before. Net loss was 137 million vs 30 million the year before. Assets dropped from 310 million to 171 million. Cash and cash equivalents dropped to 19 mil, from 52 million.
And to round out SG&A is 97million a year, however the total rev. is only 96million, add the cost of product and you have your loss. But again, that is not all your losing. They are in a box of their own making.
That's the 6th or 7th time now thge House has passed a bill to legalize marijuana. none have made it to the Senate floor. Would need 60 votes to pass.
Went thru the history, what a haul for the Stanley Brothers. Well played!